Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00318110 · ClinicalTrials.gov registry record · Phase 2
Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma
A Phase 2 study, sponsored by Center for International Blood and Marrow Transplant Research.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT00318110 is a Phase 2 study that was terminated before completion, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 4 participants.
The verdict
NCT00318110, a Phase 2 study, was terminated before completion, sponsored by Center for International Blood and Marrow Transplant Research.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what effects (good and bad) a stem cell transplant from an unrelated donor will have for patients with kidney cancer that has spread to other parts of the body (metastasized).
Interventions
- PROCEDURE NST using MUD for metastatic renal cell carcinoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00318110
The ClinicalTrials.gov registry entry for NCT00318110 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for International Blood and Marrow Transplant Research, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NST using MUD for metastatic renal cell carcinoma is the first listed.
NCT00318110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00318110 about?
NCT00318110 is a clinical study titled "Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma". The purpose of this study is to find out what effects (good and bad) a stem cell transplant from an unrelated donor will have for patients with kidney cancer that has spread to other parts of the body (metastasized).
What is the current status of trial NCT00318110?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2006-04. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00318110?
The interventions under investigation include: NST using MUD for metastatic renal cell carcinoma (PROCEDURE).
Who is sponsoring clinical trial NCT00318110?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.